“COVID-19 is uncharted territory,” writes Beth Snyder Bulk in FiercePharma, “an unprecedented global public health crisis amid a global economic collapse. Consumers who already felt ‘screwed’ by increasing insurance deductibles and drug co-pays before COVID-19 are now under even further economic stress, Jane Sarasohn-Kahn said. From the consumers’ point of view? ‘This is a public health issue and we’re broke,'” I soberly noted.
Jane quoted in FiercePharma’s analysis on how Remdesivir will be priced – Gilead in no-win situation…
By Jane Sarasohn-Kahn on 8 May 2020 in
News and Upcoming Events
Jane was named as a member of the AHIP 2024 Advisory Board, joining some valued colleagues to prepare for the challenges and opportunities facing health plans, systems, and other industry stakeholders. Looking forward to AHIP 2024 in Las Vegas come June 11-13, 2024.
Join Jane at AHIP's annual meeting in Las Vegas: I'll be speaking, moderating a panel, and providing thought leadership on health consumers and bolstering equity, empowerment, and self-care.
As a proud Big Ten alum, I'm thrilled to be invited to meet with the OSU HSMP Alumni Society to share perspectives on health care innovation.
RSS Feed
SUBSCRIBE TO BLOG UPDATES
About
Founded in 2007, the Health Populi website has over 2,000 posts, along with a library of Jane's writings and media mentions. Please use our search and filter functions to find the relevant posts for you. Make sure to sign up to our RSS feeds and join us on Twitter, too, by following @HealthyThinker.
Jane Sarasohn-Kahn, MA, MHSA